发明名称 Use of neuregulin-4 for treatment of inflammatory bowel disease and necrotizing enterocolitis
摘要 The invention provides methods, pharmaceutical compositions and kits for treating, inhibiting and/or reducing the severity of inflammatory bowel disease and necrotizing enterocolitis in a subject in need thereof by administering an effective amount of a composition comprising an activator of ErbB4.
申请公布号 US9352023(B2) 申请公布日期 2016.05.31
申请号 US201214236831 申请日期 2012.08.15
申请人 Children's Hospital Los Angeles 发明人 Frey Mark R.
分类号 A61K38/16;A61K38/18 主分类号 A61K38/16
代理机构 Nixon Peabody LLP 代理人 Vakharia-Rao Hema;Nixon Peabody LLP
主权项 1. A method for treating inflammatory bowel disease in a subject in need thereof comprising: a. providing Neuregulin-4; and b. administering a therapeutically effective amount of Neuregulin-4 to the subject so as to treat inflammatory bowel disease.
地址 Los Angeles CA US